{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:56:28Z","timestamp":1770706588125,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ijrobp.2021.11.012","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T21:33:54Z","timestamp":1637357634000},"page":"926-937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3114-4854","authenticated-orcid":false,"given":"Andrew","family":"Cook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Modh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haythem","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad","family":"Sheqwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhael","family":"Momin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Money","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamis","family":"Fakhoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Movsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzan","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.11.012_bib0001","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0002","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.soc.2015.03.001","article-title":"Epidemiology of head and neck cancer","volume":"24","author":"Rettig","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0006","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2016.04.001","article-title":"Management of chemo\/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature","volume":"120","author":"Moslemi","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0007","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1526-5900(03)00556-X","article-title":"Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review","volume":"4","author":"McNicol","year":"2003","journal-title":"J Pain"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0008","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1634\/theoncologist.2013-0001","article-title":"Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer","volume":"18","author":"Kwon","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2019.03.007","article-title":"Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies","volume":"92","author":"Smith","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0010","article-title":"Risk of chronic opioid use after radiation for head and neck cancer: A systematic review and meta-analysis","volume":"6","author":"Zayed","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0011","series-title":"StatPearls [Internet]","article-title":"Gabapentin","author":"Yasaei","year":"2021"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/JEP.S124391","article-title":"Review about gabapentin misuse, interactions, contraindications and side effects","volume":"9","author":"Quintero","year":"2017","journal-title":"J Exp Pharmacol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0014","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hed.21165","article-title":"Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy","volume":"32","author":"Bar Ad","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00455-014-9521-1","article-title":"Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer","volume":"29","author":"Starmer","year":"2014","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0016","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00455-015-9679-1","article-title":"Predictive factors for prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement and use in head and neck patients following intensity-modulated radiation therapy (IMRT) treatment: Concordance, discrepancies, and the role of gabapentin","volume":"31","author":"Yang","year":"2016","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0017","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/j.ijrobp.2020.07.924","article-title":"Prophylactic gabapentin results in dramatic reduction of narcotic utilization in head and neck cancer patients undergoing radiotherapy","volume":"108","author":"Mandia","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0018","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.anl.2016.02.012","article-title":"Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer","volume":"43","author":"Kataoka","year":"2016","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0019","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/cncr.32676","article-title":"A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer","volume":"126","author":"Hermann","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0020","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1002\/hed.26407","article-title":"Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation","volume":"42","author":"Smith","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gregoire","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0022","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"issue":"suppl","key":"10.1016\/j.ijrobp.2021.11.012_bib0023","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0024","first-page":"59","article-title":"Development and validation of a Patient-Reported Oral Mucositis Symptom (PROMS) scale","volume":"74","author":"Kushner","year":"2008","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0025","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S","article-title":"The performance status scale for head and neck cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck scale. A study of utility and validity","volume":"77","author":"List","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0026","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0027","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The functional assessment of cancer therapy scale: Development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0028","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cncr.22799","article-title":"Interpreting clinically significant changes in patient-reported outcomes","volume":"110","author":"Ringash","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0029","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijrobp.2009.10.057","article-title":"Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer","volume":"79","author":"Sanguineti","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.radonc.2013.05.021","article-title":"Predictors of PEG dependence after IMRT\u00b1chemotherapy for oropharyngeal cancer","volume":"107","author":"Sanguineti","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0031","doi-asserted-by":"crossref","first-page":"E815","DOI":"10.1002\/hed.24106","article-title":"Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis","volume":"38","author":"Mazzola","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0032","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.ijrobp.2007.02.049","article-title":"Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures","volume":"68","author":"Feng","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0033","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2008.12.017","article-title":"A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer","volume":"90","author":"Langendijk","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0034","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amjoto.2008.06.010","article-title":"Percutaneous feeding tubes in patients with head and neck cancer: Rethinking prophylactic placement for patients undergoing chemoradiation","volume":"30","author":"Lawson","year":"2009","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0035","doi-asserted-by":"crossref","first-page":"e94879","DOI":"10.1371\/journal.pone.0094879","article-title":"Development and validation of a prediction model for tube feeding dependence after curative (chemo-) radiation in head and neck cancer","volume":"9","author":"Wopken","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0036","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1200\/JCO.2014.55.0707","article-title":"Patient-reported outcomes and survivorship in radiation oncology: Overcoming the cons","volume":"32","author":"Siddiqui","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0037","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2007.06.024","article-title":"Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: A radiation therapy oncology group analysis","volume":"70","author":"Siddiqui","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0039","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-Year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0041","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-Escalate HPV): An open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0042","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): A randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0043","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.radonc.2012.06.011","article-title":"Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients - a triple blinded randomized controlled trial","volume":"104","author":"Gautam","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.012_bib0044","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1200\/JCO.19.01507","article-title":"Phase IIb, randomized, double-blind trial of GC4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer","volume":"37","author":"Anderson","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621031217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621031217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:58:59Z","timestamp":1759744739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301621031217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0360301621031217"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.11.012","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}